Abbott Claims DexCom CGM Suits Renege On Tech-Sharing Agreement
Abbott says DexCom’s patent suits involve technology that was already the subject of a settlement, and raise venue questions.
You may also be interested in...
The two suits address a total of 17 patents on elements of continuous glucose monitors, or CGMs.
For Second Time This Month, Medtronic Announces Class I FDA Recall Related To HeartWare System Component
Medtronic, Baxter and BD are all facing recalls, with Medtronic finding yet another issue with HeartWare HVAD systems. Separately, the FDA put a Baxter respiratory device recall into Class I, and BD announced a recall on intraosseous devices.
US regulators plan to hold a public meeting later this year to address concerns the devices are less accurate for people with darker skin tones.